(AOF) – Biosinax
Biosynex, market leader in rapid diagnostic tests in France, announces the extension of its partnership with Singapore-based company Credo Diagnostics Biomedical Pte Ltd for VitaPCR, Credo Diagnostics’ molecular biology platform capable of detecting infectious pathogens (including SARS -CoV-2 responsible for Covid-19) by the polymerase chain reaction (PCR) method in just 20 minutes.
The recreational craft specialist will announce its turnover for the first quarter.
On 13 December 2022, the Board of Directors, resolving with the authorization of the Shareholders’ Meeting, resolved to reduce the share capital of Crédit Agricole SA by canceling no. 16.658 million treasury shares equal to approximately 0.5% of the share capital. The capital reduction was finalized on January 13, 2023. These shares were repurchased as part of a treasury share buyback program, aimed at offsetting the dilutive effect of the 2022 capital increase reserved for employees. ‘November 11, 2022 and November 30, 2022 .
During an event organized at the French Embassy in Poland and in the presence of the French Ambassador in Poland, Frédéric Billet, EDF and Respect Energy announced the signing of a cooperation agreement for the development of nuclear projects based on the SMR Nuward at specific sites in Poland. This agreement marks the firm intention of EDF and Respect Energy to jointly undertake the development of SMR projects in Poland and confirms the keen interest in Nuward technology.
The company specializing in genetically engineered research models for the pharmaceutical industry and academic research laboratories will release fourth-quarter revenue.
The company specialized in in vitro diagnostics will reveal the revenues of the fourth quarter.
The AOF information reproduced on Capital.fr is taken from the AOF information service. This information is protected by intellectual property rights held by OPTION FINANCE SAS, publisher of the AOF real-time stock market information service, and its contributors. Consequently, any reproduction, copy, duplication, modification, transfer, redistribution, translation, commercial or non-commercial exploitation, creation of a hyperlink or reuse in any way of this information is subject to the prior written consent of OPTION FINANCE SAS and its contributors . AOF can be reached at the following address firstname.lastname@example.org OPTION FINANCE SAS collects your data from the sources it considers to be the most secure. However, except for its gross negligence, OPTION FINANCES SAS and its collaborators do not guarantee in any way the absence of errors and defects, even if hidden, nor the exhaustive nature or lack of conformity for any use of this data and OPTION FINANCE SAS or one of its contributors, and cannot be held responsible for any delays or interruptions that may affect access to them. The user of the OPTION FINANCE SAS service will use the AOF data at his own risk and shall hold OPTION FINANCE SAS and its contributors harmless from any claim arising from such use.
Get our latest news
Every morning, the information to remember about financial markets.